OCEA CIK: 1869974

Ocean Biomedical, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY21 – FY24

Assets

(positive)
Change from FY21 to FY24
millions USD
FY21:
1.55
FY22:
1.84
FY23:
2.11
FY24:
0.81
(positive)
Change from FY21 to FY24
millions USD
FY21:
107
FY22:
0
FY23:
3.39
FY24:
0.09
Total assets
Change from FY21 to FY24
millions USD
FY21:
109
FY22:
1.84
FY23:
5.50
FY24:
0.90

Liabilities & Equity

(negative)
Change from FY21 to FY24
millions USD
FY21:
0.25
FY22:
12.7
FY23:
30.0
FY24:
33.9
(negative)
Change from FY21 to FY24
millions USD
FY21:
3.15
FY22:
0
FY23:
66.3
FY24:
64.6
(positive)
Change from FY21 to FY24
millions USD
FY21:
−1.84
FY22:
−10.8
FY23:
−90.8
FY24:
−97.6
Total liabilities & equity
Change from FY22 to FY24
millions USD
FY21:
–
FY22:
1.84
FY23:
5.50
FY24:
0.90

All amounts in millions USD Data sources:SEC EDGARTwelve Data